In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device/Diagnostics Quarterly Deal-Making Statistics, Q1 2017

A look at financing, M&A and alliance activity January–March 2017

Executive Summary

Medtech companies brought in $2.3 billion in financing in Q1 2017, a slight decrease from Q4 2016; device M&A deals totaled $5.8 billion, a sharp decline from the prior quarter, but there were some billion-dollar deals. Q1 diagnostics financings – totaling $1.2 billion (thanks to a $900 million Series B round by cancer diagnostics company Grail) – showed a significant increase over the preceding quarter, as did the Q1 M&As at $700 million versus the previous $87 million.

Advertisement

Related Content

M&A Deals Analysis: February Sees Billion-Dollar Buys Bite
Big Pharma Helps Pour $900m Into Grail
Integra Aims To Bolster Neurology Portfolio With J&J Codman Buy
Hologic Stitches Medical Aesthetics Into Women's Health
Allergan Pays $2bn-Plus For Zeltiq, Expanding Aesthetics Business
Verily Mulls Asian Acquisitions, Partnerships With $800m Temasek Cash
Do Hill-Rom, PerkinElmer, Integra Deals Signal 2017 M&A Acceleration?

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV005109

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel